Navigation Links
U.S. EPA Approves Registration of Antimicrobial Copper Alloys
Date:3/25/2008

Copper, brass and bronze kill pathogens - including 'superbug'

MRSA-responsible for hospital- and community-acquired infections

NEW YORK, March 25 /PRNewswire/ -- The U.S. Environmental Protection Agency (EPA) has approved the registration of antimicrobial copper alloys, with public health claims. These public health claims acknowledge that copper, brass and bronze are capable of killing harmful, potentially deadly bacteria. Copper is the first solid surface material to receive this type of EPA registration, which is supported by extensive antimicrobial efficacy testing.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080325/NYTU054 )

The EPA registration is based on independent laboratory testing using EPA-prescribed protocols that demonstrate the metals' ability to kill specific disease-causing bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA). MRSA is one of the most virulent strains of antibiotic-resistant bacteria and a common cause of hospital- and community-acquired infections.

Testing under EPA-approved protocols demonstrates that copper, brasses and bronzes are effective against a number of disease-causing bacteria. For example, one study shows that on copper alloy surfaces, greater than 99.9% of MRSA "superbugs" are killed within two hours at room temperature.

The following statements are included in the registration: "When cleaned regularly, antimicrobial copper alloys surfaces kill greater than 99.9% of (specific) bacteria within two hours, and continue to kill more than 99% of (these) bacteria even after repeated contamination," and, "The use of a copper alloy surface is a supplement to and not a substitute for standard infection control practices; users must continue to follow all current infection control practices, including those practices related to cleaning and disinfection of environmental surfaces. The copper alloy surface material has been shown to reduce microbial contamination, but it does not necessarily prevent cross contamination."

Widely publicized statistics from the Centers for Disease Control and Prevention (CDC) estimate infections acquired in U.S. hospitals affect two million individuals every year and result in nearly 100,000 deaths annually. The use of copper alloys for frequently touched surfaces, as a supplement to existing CDC-prescribed hand-washing and disinfection regimens, has far-reaching implications. Potential uses, that include door and furniture hardware, bed rails, intravenous (IV) stands, dispensers, faucets, sinks and work stations, can help reduce the amount of disease-causing bacteria in patient rooms.

Unlike coatings or other materials treatments, the antibacterial efficacy of copper metals won't wear away: they can offer solid, long-term protection. Discussions are ongoing with major hospital equipment manufacturers about the development of appropriate copper-based products. For additional information about antimicrobial copper, please visit http://www.copper.org.

TO RECEIVE B-ROLL BY SATELLITE C-BAND

TUESDAY, MARCH 25, 2008 2:00-2:15 PM EDT (11:00-11:15 AM PDT)

G-25(c); TRANSPONDER-23 D/L 4160

(V), Audio 6.2/6.8

The Copper Development Association is the information, education, market and technical development arm of the copper, brass and bronze industries in the USA. CDA is a member of the International Copper Association, LTD. network.


'/>"/>
SOURCE The Copper Development Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Arizona Senate Approves Smoking Cessation Treatments for State Medicaid Beneficiaries
2. CMS Approves Home Sleep Testing for Diagnosis of OSA; AASM Experts Available for Comment
3. FDA Approves Abbotts FreeStyle Navigator(R) Continuous Glucose Monitoring System
4. FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting
5. FDA Approves Luvox(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
6. FDA Approves NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old
7. U.S. Court Approves AK Steels VEBA Health Care Settlement With Middletown Works Retirees
8. Securian Board Approves 8 Officer Promotions
9. MGT Capital Investments, Inc. Approves Share Buyback Program
10. Kaiser Permanente Approves $29 Million in Community Benefit Grants
11. Otter Tail Corporation Reports Record Revenues and Net Income From Continuing Operations for 2007; Earnings Per Share of $1.78; Board Approves Dividend Increase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... With over 60 percent of acute ... for a sustainable product to aid in the rehabilitation process has steadily increased. Ekso ... of individuals with hemiplegia due to stroke. , Ekso Bionics has now received clearance ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... is bolstered by inspiring human-interest stories, courtesy of awareness-driven celebrities and thought leaders. ... from leading advocates, associations and industry leaders such as Bioness. , As ...
(Date:5/27/2016)... ... May 27, 2016 , ... Beleza Medspa ... fat composition regulations. This is the first time that Coolsculpting is being used ... least every six months to ensure they meet the prescribed body-fat standard, measured by ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees in ... come courtesy of leaders in the nursing and health care industry. It also provides ... associations—namely Abilene Christian University. , As the nursing industry is coming out of ...
(Date:5/27/2016)... ... May 27, 2016 , ... With a team of ... food industries. Aside from its GMP accreditation, Validation Center is also a registered ... products, services and staff. , Validation Center is ISO17025 accredited and only offers ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... , May 24, 2016  Diana Russell suffers from ... organs from the inside out.  This disease has put ... on her children and grandchildren to leave her home.  ... Diana,s family cannot haul the wheelchair.  So if there ... car, and Diana is left to wait for the ...
(Date:5/24/2016)... 24, 2016 Celsion Corporation (NASDAQ: ... today provided an update on its ongoing OVATION ... combining GEN-1, the Company,s DNA-based immunotherapy, with the ... patients with advanced ovarian cancer who will undergo ... is an IL-12 DNA plasmid vector formulated as ...
(Date:5/24/2016)... , May 24, 2016 ... doble terapia del mundo, introduce catéteres para la ... OrbusNeich, una compañía global especializada en el ... ha expandido su cartera incluyendo productos para tratar ... y Scoreflex™ PTA son los dispositivos de primera ...
Breaking Medicine Technology: